... that both memory and naïve B cells can be activated by the drug CP-870, 893 , and this CP870, 893 effect can be increased by the addition of < /b> CpG ODN 2006 Naïve B cells, as defined by lack of < /b> CD27 ... of < /b> resting human < /b> B cells consistent with licensed APC Clinically, for patients receiving CP-870, 893 , there may be a link between the ability of < /b> CP-870, 893 to activate B cells and the rapid (but ... CP-870, 893 on B cell activation < /b> and B cell stimulation of < /b> T cells, and we analyzed the effects of < /b> co-stimulating B cells with the TLR9 agonist CpG ODN 2006 Materials and methods In mice, agonist CD40...